TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33572909

Group type: EXPERIMENTAL
Intervention: HIIT (n = 28) - high-intensity interval training with TRX, 90-95% max HR, 12 weeks, 2 times/week, 45 min/session
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: MIIT (n = 27) - moderate-intensity interval training with TRX, 70% max HR, 12 weeks, 2 times/week, 45 min/session
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (CG) (n = 27) - continued daily lifestyle
Number of subjects: 82
Study: 35742753

Group type: EXPERIMENTAL
Intervention: Intermittent Exercise (IE)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Continuous Exercise (CE)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control
Number of subjects: 7
Study: 36281668

Group type: EXPERIMENTAL
Intervention: Medication therapy management
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 90
Study: 34897869

Group type: EXPERIMENTAL
Intervention: Deep breathing exercise with Triflo
Number of subjects: 44

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 44
Study: 33148768

Group type: EXPERIMENTAL
Intervention: Atopic dermatitis (by UK criteria)
Number of subjects: 7275

Group type: EXPERIMENTAL
Intervention: Atopic dermatitis (by ISAAC)
Number of subjects: 7275

Group type: EXPERIMENTAL
Intervention: Asthma
Number of subjects: 7275

Group type: EXPERIMENTAL
Intervention: Rhinitis
Number of subjects: 7275

Group type: COMPARATOR
Intervention: Atopic dermatitis (severe disease)
Number of subjects: 7275

Group type: COMPARATOR
Intervention: Asthma (severe disease)
Number of subjects: 7275

Group type: COMPARATOR
Intervention: Rhinitis (severe disease)
Number of subjects: 7275

Group type: COMPARATOR
Intervention: Asthma (highest quintile wealth score)
Number of subjects: 7275

Group type: COMPARATOR
Intervention: Rhinitis (highest quintile wealth score)
Number of subjects: 7275

Group type: EXPERIMENTAL
Intervention: Having atopic dermatitis (ISAAC)
Number of subjects: 7275

Group type: EXPERIMENTAL
Intervention: Asthma and rhinitis association
Number of subjects: 7275
Study: 34175192

Group type: EXPERIMENTAL
Intervention: Active deep rTMS targeting the posterior superior insula (PSI)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 31
Study: 35502600

Group type: EXPERIMENTAL
Intervention: ravulizumab
Number of subjects: 441
Study: 34919219

Group type: EXPERIMENTAL
Intervention: Atorvastatin (oral) after surgery for at least 1 week
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no atorvastatin postoperatively)
Number of subjects: 49
Study: 35833967

Group type: EXPERIMENTAL
Intervention: Hot water immersion in fresh water (FWB)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Hot water immersion in salt water (SWB; 5.0%wt/vol Epsom salt)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Both FWB and SWB
Number of subjects: 13

Group type: COMPARATOR
Intervention: RWL followed by recovery process
Number of subjects: 13
Study: 34216729

Group type: EXPERIMENTAL
Intervention: MRI-detected osteophytes in participants with bone marrow lesions (BMLs)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: MRI-detected osteophytes in participants with effusion-synovitis
Number of subjects: 334

Group type: COMPARATOR
Intervention: MRI-detected osteophytes in participants without baseline BMLs or effusion-synovitis
Number of subjects: 334
Study: 35442430

Group type: EXPERIMENTAL
Intervention: Laparoscopic 270° posterior partial fundoplication (PF)
Number of subjects: 456

Group type: COMPARATOR
Intervention: Laparoscopic 360° total fundoplication (TF)
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Both PF and TF
Number of subjects: 456
Study: 34477217

Group type: EXPERIMENTAL
Intervention: Traditional recruitment methods (physician referral, newspaper and radio advertisements, letterbox drops, posters/flyers, word‐of‐mouth)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Modern recruitment methods (patient recruitment services, social media, Google advertisements, websites, email)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combination of traditional and modern recruitment methods
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional and modern recruitment methods
Number of subjects: 100
Study: 32580480

Group type: EXPERIMENTAL
Intervention: Muscle Energy Technique (MET)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Thrust Technique
Number of subjects: 60

Group type: COMPARATOR
Intervention: Simulated Technique (Control)
Number of subjects: 60
Study: 34106317

Group type: EXPERIMENTAL
Intervention: Oxymorphone (1.8, 3.2, 5.6, 10, 18, 32 mg/70 kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Hydromorphone (1.8, 3.2, 5.6, 10, 18 mg/70 kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Oxycodone (18, 32, 56 mg/70 kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Morphine (18, 32 mg/70 kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 32025883

Group type: EXPERIMENTAL
Intervention: Ozone application
Number of subjects: 105

Group type: COMPARATOR
Intervention: 2% chlorhexidine digluconate (CHX)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Conventional stepwise excavation with no disinfectants (Control)
Number of subjects: 105
Study: 35545122

Group type: EXPERIMENTAL
Intervention: CADe-assisted colonoscopy
Number of subjects: 800

Group type: COMPARATOR
Intervention: HDWL colonoscopy alone
Number of subjects: 800
Study: 33706305

Group type: EXPERIMENTAL
Intervention: 1.5% ammonium fluoride varnish (Fluor Protector S)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 5% NaF varnish (Duraphat)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Professional tooth-cleaning (control group)
Number of subjects: 180
Study: 32383277

Group type: EXPERIMENTAL
Intervention: Assay-guided treatment (AGT; N=151)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU; N=153)
Number of subjects: 304
Study: 33871246

Group type: EXPERIMENTAL
Intervention: Isoinertial resistance training
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Free-weight resistance training
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study: 32081489

Group type: EXPERIMENTAL
Intervention: Proxima A (bilateral GA)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Proxima B (fellow eye CNV cohort)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Proxima B (fellow eye intermediate AMD cohort)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Proxima A (BCVA)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Proxima B (fellow eye CNV cohort, BCVA)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Proxima B (fellow eye intermediate AMD cohort, BCVA)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Proxima A (LLVA)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Proxima B (fellow eye CNV cohort, LLVA)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Proxima B (fellow eye intermediate AMD cohort, LLVA)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Proxima B (intermediate AMD cohort)
Number of subjects: 495
Study: 35143365

Group type: EXPERIMENTAL
Intervention: Active rTMS (10 Hz stimulation for 20 minutes, 1200 pulses per session for five consecutive days)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham rTMS (control)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 26
Study: 34526086

Group type: COMPARATOR
Intervention: Placebo-controlled trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Open-label trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: At-risk priority groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blinded stepped-wedge cross-over design
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blinded active-controlled stepped-wedge cross-over trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomised stepped-wedge community trials
Number of subjects: 0
Study: 32285810

Group type: EXPERIMENTAL
Intervention: Medication
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Training in the 'Asthma School'
Number of subjects: 75

Group type: COMPARATOR
Intervention: Basic therapy
Number of subjects: 75
Study: 33921101

Group type: EXPERIMENTAL
Intervention: Positive verbal suggestion
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Negative verbal suggestion
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Neutral verbal suggestion
Number of subjects: 42
Study: 33041038

Group type: EXPERIMENTAL
Intervention: 30 mL of a 1:1 fish to flaxseed oil supplement in colostrum
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 60 mL of a 1:1 fish to flaxseed oil supplement in colostrum
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 120 mL of a 1:1 fish to flaxseed oil supplement in colostrum
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0 mL of a 1:1 fish to flaxseed oil supplement in colostrum (control group)
Number of subjects: 24
Study: 34635140

Group type: EXPERIMENTAL
Intervention: Wearable + Symptom Data Algo (Ava bracelet data + Daily Symptom Diary data)
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Symptom Only Algo (Daily Symptom Diary data alone)
Number of subjects: 20000
Study: 32705829

Group type: EXPERIMENTAL
Intervention: Tongdu Tiaoshen needling (electroacupuncture at Baihui (GV20), Shenting (GV24), Yintang (EX-HN3), bilateral Shenmen (HT7), and bilateral Sanyinjiao (SP6))
Number of subjects: 60

Group type: COMPARATOR
Intervention: Superficial acupuncture (at Shousanli (LI10), Futu (ST32), and Feiyang (BL58))
Number of subjects: 60
Study: 35273520

Group type: EXPERIMENTAL
Intervention: GATE
Number of subjects: 16
Study: 32620131

Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training (RAGT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Non-assisted gait training (NAGT)
Number of subjects: 10
Study: 34923371

Group type: EXPERIMENTAL
Intervention: Attention Bias Modification (ABM)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84

Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 84
Study: 32881648

Group type: EXPERIMENTAL
Intervention: Low-volume high-intensity interval training (HIIT)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Moderate-intensity continuous training (MICT)
Number of subjects: 99
Study: 33915381

Group type: EXPERIMENTAL
Intervention: Parent management training (PMT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 42
Study: 33016505

Group type: EXPERIMENTAL
Intervention: Fibroblast growth factor 23 (FGF23) concentrations
Number of subjects: 2309
Study: 34259393

Group type: EXPERIMENTAL
Intervention: ART-40W
Number of subjects: 133

Group type: COMPARATOR
Intervention: ART-Def
Number of subjects: 133

Group type: COMPARATOR
Intervention: CHU
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: CLWH
Number of subjects: 133
Study: 33114566

Group type: EXPERIMENTAL
Intervention: Micronized lipid‐based carotenoid supplement, Lumega‐Z (LM)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: PreserVision Age‐Related Eye Disease Study 2 (AREDS‐2) soft gel (PV)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (ocular normal individuals)
Number of subjects: 68
Study: 32088134

Group type: EXPERIMENTAL
Intervention: Corneal topography assessment of multifocal contact lenses (MCLs) centration
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Manual assessments by 4 practitioners using 3 different algorithms
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Intra-class correlation coefficient among the 3 readings for each manual procedure
Number of subjects: 22
Study: 34379236

Group type: EXPERIMENTAL
Intervention: Enhanced Intervention
Number of subjects: 199

Group type: COMPARATOR
Intervention: Original Intervention
Number of subjects: 199
Study: 32980253

Group type: EXPERIMENTAL
Intervention: Brief Behavioral Activation for Improving Social Connectedness
Number of subjects: 0

Group type: COMPARATOR
Intervention: Friendly visit
Number of subjects: 0
Study: 32677614

Group type: COMPARATOR
Intervention: Mitomycin C (MMC) alone (0.1 mg/ml for 1 minute)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC) plus Ologen
Number of subjects: 50
Study: 36089222

Group type: EXPERIMENTAL
Intervention: 0.5% EGCG with ethanol wet-bonding for 60 s
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1% EGCG with ethanol wet-bonding for 60 s
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5% EGCG/ethanol solutions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.1% EGCG
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5% EGCG
Number of subjects: 0

Group type: COMPARATOR
Intervention: Absolute ethanol wet-bonding for 60 s
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study: 36131172

Group type: EXPERIMENTAL
Intervention: Heparin rota-flush solution
Number of subjects: 200

Group type: COMPARATOR
Intervention: Traditional rota-flush solution
Number of subjects: 200
Study: 32946605

Group type: EXPERIMENTAL
Intervention: Stem cell transplantation
Number of subjects: 1552

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 1552
Study: 36482453

Group type: EXPERIMENTAL
Intervention: BEAR (Blended E‐health for children at eArly Risk)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Care-as-usual (CAU)
Number of subjects: 88
Study: 33506496

Group type: EXPERIMENTAL
Intervention: Propofol plus dexmedetomidine
Number of subjects: 66

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 66
Study: 32717669

Group type: EXPERIMENTAL
Intervention: Smart glasses
Number of subjects: 20

Group type: COMPARATOR
Intervention: Smartphone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Paper-based system
Number of subjects: 20
Study: 36036925

Group type: EXPERIMENTAL
Intervention: Vamorolone, 6 mg/kg per day
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Vamorolone, 2 mg/kg per day
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Prednisone, 0.75 mg/kg per day
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: All treatment groups (including vamorolone and prednisone)
Number of subjects: 133
Study: 33714372

Group type: EXPERIMENTAL
Intervention: EBRT (External Beam Radiotherapy)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 199
Study: 33174590

Group type: EXPERIMENTAL
Intervention: Heated humidified high-flow nasal cannula (HHHFNC)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (nCPAP)
Number of subjects: 128
Study: 32684473

Group type: EXPERIMENTAL
Intervention: Moderate milk replacer (0.66 kg DM) with gradual weaning (21-d step-down)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High milk replacer (up to 1.1 kg DM) with abrupt weaning (7-d step-down)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High milk replacer (up to 1.1 kg DM) with gradual weaning (21-d step-down)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Moderate milk replacer (0.66 kg DM) with abrupt weaning (7-d step-down)
Number of subjects: 50
Study: 35831153

Group type: EXPERIMENTAL
Intervention: Evolocumab 140 mg every 2 weeks combined with atorvastatin 40 mg/day and ezetimibe 10 mg/day
Number of subjects: 136

Group type: COMPARATOR
Intervention: Atorvastatin 40 mg/day and ezetimibe 10 mg/day (Control)
Number of subjects: 136
Study: 34076400

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.045% lotion
Number of subjects: 1542

Group type: COMPARATOR
Intervention: Vehicle lotion
Number of subjects: 1542
Study: 32135208

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks (adults)
Number of subjects: 1505

Group type: EXPERIMENTAL
Intervention: Dupilumab 200 mg or 300 mg every 2 weeks (adolescents)
Number of subjects: 1505

Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 1505

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1505
Study: 35507726

Group type: EXPERIMENTAL
Intervention: Actual table tennis training
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Simulated table tennis (exergame)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no additional training)
Number of subjects: 48
Study: 34823494

Group type: EXPERIMENTAL
Intervention: High intensity exercise with self-regulatory behaviour change techniques (BCTs)
Number of subjects: 577

Group type: COMPARATOR
Intervention: High intensity exercise without self-regulatory behaviour change techniques (BCTs)
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Low-to-moderate intensity exercise with self-regulatory behaviour change techniques (BCTs)
Number of subjects: 577

Group type: COMPARATOR
Intervention: Low-to-moderate intensity exercise without self-regulatory behaviour change techniques (BCTs)
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Higher health-related quality-of-life (HRQoL)
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Higher exercise motivation
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Higher exercise expectations
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: History of tobacco use
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Greater BMI increases during the exercise intervention
Number of subjects: 577
Study: 36398123

Group type: EXPERIMENTAL
Intervention: Liquid-based cytology (LBC)
Number of subjects: 3677

Group type: EXPERIMENTAL
Intervention: Visual inspection with acetic acid and Lugol's iodine (VIA/VILI)
Number of subjects: 3677

Group type: COMPARATOR
Intervention: Direct COLP for HPV16/18+
Number of subjects: 3677

Group type: COMPARATOR
Intervention: Direct COLP for other hrHPV subtypes+
Number of subjects: 3677

Group type: EXPERIMENTAL
Intervention: LBC triage for other hrHPV subtypes+
Number of subjects: 3677
Study: 33729175

Group type: EXPERIMENTAL
Intervention: GSV sparing
Number of subjects: 36

Group type: COMPARATOR
Intervention: GSV stripping
Number of subjects: 36
Study: 34215610

Group type: EXPERIMENTAL
Intervention: Implementation strategy employing peer-led educational outreach, a clinical support tool, and peer support network to implement a TB treatment adherence intervention.
Number of subjects: 88
Study: 32194058

Group type: EXPERIMENTAL
Intervention: HAT therapy (hydrocortisone, ascorbic acid, thiamine)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Comparator group (placebo)
Number of subjects: 137
Study: 35078522

Group type: EXPERIMENTAL
Intervention: Unplugged program (Yo Sé Lo Que Quiero)
Number of subjects: 8400

Group type: COMPARATOR
Intervention: Standard school preventive curricula
Number of subjects: 8400
Study: 33982452

Group type: EXPERIMENTAL
Intervention: TLPLDC vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32474584

Group type: EXPERIMENTAL
Intervention: Potentially inappropriate medication (PIM) use
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Long-term benzodiazepines
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors without appropriate indication
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Proton-Pump Inhibitors (PPIs) without appropriate indication
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Increasing number of PIMs
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: PIM use
Number of subjects: 448
Study: 35502947

Group type: EXPERIMENTAL
Intervention: Topical Cannabidiol (CBD)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral Cannabidiol (CBD)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Human studies of CBD
Number of subjects: 12
Study: 34342172

Group type: EXPERIMENTAL
Intervention: Apixaban 0.5 mg IV
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Apixaban 1.25 mg IV
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Apixaban 2.5 mg IV
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Apixaban 3.75 mg IV
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Apixaban 5 mg IV
Number of subjects: 8

Group type: COMPARATOR
Intervention: Apixaban 5 mg oral
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo IV
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo oral
Number of subjects: 8
Study: 35839030

Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Selective nerve root block (SNRB)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Nonsteroidal antiinflammatory drugs (NSAIDs)
Number of subjects: 81
Study: 33232555

Group type: EXPERIMENTAL
Intervention: Codeine (60 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (glucose syrup)
Number of subjects: 19
Study: 35925582

Group type: EXPERIMENTAL
Intervention: mVRBT‐MRc
Number of subjects: 25

Group type: COMPARATOR
Intervention: aSRT‐MRc
Number of subjects: 25
Study: 36270544

Group type: EXPERIMENTAL
Intervention: Power training (PT) + high-intensity interval training (HIIT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Traditional strength training (TST) + high-intensity interval training (HIIT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Power training (PT) + HIIT
Number of subjects: 35

Group type: COMPARATOR
Intervention: Traditional strength training (TST) + HIIT
Number of subjects: 35
Study: 34916642

Group type: COMPARATOR
Intervention: Conventional brain-guided (free-hand) implant surgery
Number of subjects: 90

Group type: COMPARATOR
Intervention: Dynamic computer-assisted implant surgery (dCAIS)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Static computer-assisted implant surgery (sCAIS)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Overall patient satisfaction
Number of subjects: 90
Study: 34907003

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO2) therapy, ≥5 sessions (1 per day) for 90 minutes at 1.45 ATA for 7 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard treatment for respiratory symptoms for 7 days
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO2) therapy
Number of subjects: 40
Study: 33443079

Group type: EXPERIMENTAL
Intervention: Clazakizumab (25 mg, 4-weekly subcutaneous injections for 12 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Clazakizumab (25 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32464019

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Blood clot alone (Control)
Number of subjects: 7
Study: 33793377

Group type: EXPERIMENTAL
Intervention: Service attendance as a congregation-level variable
Number of subjects: 239

Group type: COMPARATOR
Intervention: Service attendance
Number of subjects: 239
Study: 34271274

Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 164

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 164